Madam Wat’s: Fight Stage 4 Breast Cancer with Strength, Hope, and ECCT

Madam Wat Mei Ying, Malaysia. In 2011, Mei Ying was diagnosed with breast cancer. The tumor measured 2.5cm which grew to 9cm in 2015 but she faced it with unwavering determination. She underwent immunotherapy and low- dose chemotherapy, responding well to treatment. Against the odds, she became cancer- free for five full years — a period filled with gratitude and a return to a sense of normalcy.

However, in 2020, life took another challenging turn. Mei Ying underwent a kidney transplant in year 2000 which heartbreakingly failed after 9.5 years. Since then, she has been dependent on dialysis three times a week, a physically and emotionally draining routine. The transplant drugs contributed towards the cancer. She was prescribed HERS treatment, a form of hormone therapy, and bravely endured 18 cycles. However, the side effects became unbearable — relentless itching and sleepless nights left her exhausted. Six weeks before starting ECCT, she had to pause HERS therapy to recover. By then, rashes had developed on both her breasts. In late November 2022, another setback struck: Mei Ying suffered a mild ischemic stroke, affecting the right side of her body. She struggled with balance, temporarily could not drive, and even lost the ability to hold a pen.

By this time, the cancer had also spread to her bones, particularly near the collarbone and T1 spine, causing pain. Radiation therapy was used to help relieve the discomfort. Two painful lumps also appeared near her breast, pressing against the skin. Although tests confirmed they were not tumors, the discomfort was real. Her body had become fragile — she could not tolerate nutritional supplements like Ensure due to excessive mucus. Instead, she relied on soy milk powder to maintain her strength. Despite everything, Mei Ying remained mentally strong and emotionally grounded. She was determined to live meaningfully, find balance in her treatments together with supplements and rebuild her strength. It was during this time that her integrative oncologist recommended ECCT as an added treatment to help control her disease. She decided to start ECCT in December 2022 to Fight Stage 4 Breast Cancer.

On 15 December 2022, Mei Ying began ECCT therapy alongside her other supportive treatments and supplements. This marked the start of a new phase — one focused not only on fighting cancer but also on healing gently and improving her quality of life. Unfortunately, the rashes developed post HERS therapy has cause her skipping some ECCT treatment due to extreme discomfort.

In February 2023, a follow-up PET-CT scan suggested progression in some areas, particularly in the liver and lymph nodes. The ECCT medical team advised her to consider a more aggressive treatment plan. She diligently use ECCT blanket with more aggressive treatment plan.

By June 2023, Mei Ying began experiencing dizziness. A brain MRI showed no metastases at that time, providing temporary relief. However, a few months later, a repeat scan confirmed the presence of brain metastases.

This marked a new turning point: Mei Ying became even more committed to using ECCT, wearing the helmet diligently each day alongside the body treatment. Despite the brain lesions, the rest of her body remained remarkably stable with ECCT blanket.

A PET-CT in August 2023 once again showed a mixed response — some lesions decreased in activity and no new areas of spread were detected. Encouragingly, her liver function began to improve significantly, with her alkaline phosphatase (ALP) levels dropping from a peak of 662 in early 2023 to just 89 by the end of 2024.

In January 2024, her PET-CT scan has finally confirmed stable disease. While the cancer had not disappeared, it had stopped progressing — a major milestone signaling that her disease was under control and her body was responding positively to the combination of ECCT and conventional therapies.

Madam Wat Mei Ying’s journey continues, but her story is already one of extraordinary hope and resilience. While the cancer remains, it is no longer progressing. With ECCT as a key part of her long-term care plan, she has gained stability and improved liver function. Our medical team continues to support her at every step. Every day, Mei Ying fights diligently and positively — not just to survive, but to live meaningfully.